Tourmaline Bio Inc.

NASDAQ: TRML · Real-Time Price · USD
22.50
0.11 (0.49%)
At close: Aug 15, 2025, 3:59 PM
22.13
-1.62%
After-hours: Aug 15, 2025, 05:03 PM EDT

Tourmaline Bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 40K n/a n/a n/a 2.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a 12K 20K 10K 10K 10K 1.14M 9K 261K 639K 553K 596K 593K 488K 188K 167K 133K 135K
Gross Profit
n/a -12K 20K -10K -10K -10K 1.14M -9K -261K -639K -553K -596K -593K -488K -188K -167K -133K -135K
Operating Income
-25.97M -26.23M -25.81M -24.44M -21.97M -17.52M -14.89M -6.64M -16.37M -7.5M -4.92K -1.96K -12.56K -264 -14.39M -13.06M -11.06M -9.01M
Interest Income
n/a 3.26M 3.57M 4.26M 4.48M 4.21M 1.99M 1.05M n/a n/a n/a n/a n/a n/a n/a 116K n/a n/a
Pretax Income
-23.09M -22.97M -22.23M -20.18M -17.49M -13.31M -12.9M -5.59M -16.13M -7.5M -4.92K -1.96K -12.56K -264 -14.24M -12.94M -11.35M -9.3M
Net Income
-23.09M -22.97M -22.23M -20.18M -17.49M -13.31M -12.9M -7.01M -16.13M -7.5M -4.92K -1.96K -12.56K -264 -14.24M -12.94M -11.35M -9.3M
Selling & General & Admin
6.34M 5.97M 5.27M 5.11M 6.23M 6.14M -8.28M 9.11M 1.92M 1.36M 1.13K 702.00 288.00 58.00 3.61M 3.71M 3.35M 2.4M
Research & Development
19.63M 20.26M 20.55M 19.33M 15.73M 11.38M 14.6M 267K 14.45M 6.14M 3.79K 1.25K 12.27K 206.00 10.59M 9.18M 7.57M 6.47M
Other Expenses
n/a n/a n/a n/a n/a n/a 8.57M -2.74M 245K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
25.97M 26.23M 25.82M 24.44M 21.96M 17.52M 14.89M 6.64M 16.37M 7.5M 4.92K 1.96K 12.56K 264.00 14.2M 12.89M 10.92M 8.87M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 295K 294K
Selling & Marketing Expenses
n/a n/a 10K n/a -10K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.97M 26.23M 25.84M 24.44M 21.97M 17.52M 14.89M 6.64M 16.37M 7.5M 4.92K 1.96K 12.56K 264.00 14.39M 13.06M 11.06M 9.01M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.3M -18.41M -17.5M -17.77M n/a n/a n/a n/a
Shares Outstanding (Basic)
25.75M 25.69M 25.8M 25.77M 25.72M 24.08M 16M 20.34M 12.41M 20.34M 10.88M 10.88M 10.88M 10.88M 4.09M 4.07M 2.74M 3.83M
Shares Outstanding (Diluted)
25.75M 25.69M 25.8M 25.77M 25.72M 24.08M 16M 20.34M 12.41M 20.34M 10.88M 10.88M 10.88M 10.88M 4.09M 4.07M 2.74M 3.83M
EPS (Basic)
-0.9 -0.89 -0.86 -0.78 -0.68 -0.55 -0.81 -0.34 -1.3 -0.37 -0.00 -0.00 -0.00 -0.00 -3.48 -3.18 -4.15 -2.43
EPS (Diluted)
-0.9 -0.89 -0.86 -0.78 -0.68 -0.55 -0.81 -0.34 -1.3 -0.37 -0.00 -0.00 -0.00 -0.00 -3.48 -3.18 -4.15 -2.43
EBITDA
-25.97M -26.23M -25.84M -24.43M -21.97M -17.51M -14.88M -8.26M -16.37M -7.5M 36.95M -18.41M -17.5M -17.77M -14.2M -12.77M -10.92M -8.87M
EBIT
-23.09M -22.97M -22.23M -24.44M -21.97M -17.52M -14.89M -9.38M -16.37M -7.5M 36.95M -19.82M -18.1M -18.26M -226K -12.94M -11.06M -9.01M
Depreciation & Amortization
n/a 12K 9K 10K 10K 10K 11K 1.13M 7K 6K 5.00 1.96K 12.56K 264.00 188K 167K 133K 135K